Oyster Point Pharma Balance Sheet Health
Financial Health criteria checks 0/6
Key information
-415.4%
Debt to equity ratio
US$92.22m
Debt
| Interest coverage ratio | n/a |
| Cash | US$68.80m |
| Equity | -US$22.20m |
| Total liabilities | US$131.40m |
| Total assets | US$109.20m |
Recent financial health updates
Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?
Nov 08
Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?
Dec 24Oyster Point Pharma (NASDAQ:OYST) Is In A Good Position To Deliver On Growth Plans
Oct 15Here's Why We're Not Too Worried About Oyster Point Pharma's (NASDAQ:OYST) Cash Burn Situation
May 10Companies Like Oyster Point Pharma (NASDAQ:OYST) Are In A Position To Invest In Growth
Dec 18Recent updates
Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?
Nov 08Oyster Point's nasal spray to be covered by largest Medicare pharmacy benefit manager
Aug 17Oyster Point Pharma, Inc. (NASDAQ:OYST) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Aug 14Oyster Point stock rises 11% after H.C. Wainwright begins coverage with Buy rating
Jul 18Oyster Therapeutics: State Of Business Is Confounding
Jun 30Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?
Dec 24Oyster Point Pharma (NASDAQ:OYST) Is In A Good Position To Deliver On Growth Plans
Oct 15Oyster Point Pharma starts enrollment in mid-stage Neurotrophic Keratopathy study
Jun 21Here's Why We're Not Too Worried About Oyster Point Pharma's (NASDAQ:OYST) Cash Burn Situation
May 10Need To Know: Oyster Point Pharma, Inc. (NASDAQ:OYST) Insiders Have Been Buying Shares
Feb 09
Oyster Point Pharma files US application for its lead program in dry eye disease
Dec 18Companies Like Oyster Point Pharma (NASDAQ:OYST) Are In A Position To Invest In Growth
Dec 18Oyster Point Pharma, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 06Financial Position Analysis
Short Term Liabilities: OYST has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: OYST has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: OYST has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: OYST's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OYST has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: OYST has less than a year of cash runway if free cash flow continues to reduce at historical rates of 49.1% each year
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/01/04 22:32 |
| End of Day Share Price | 2022/12/30 00:00 |
| Earnings | 2022/09/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Oyster Point Pharma, Inc. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daniil Gataulin | Chardan Capital Markets, LLC |
| Matthew Caufield | H.C. Wainwright & Co. |
| Anupam Rama | J.P. Morgan |